{"id":"omeprazole-plus-amoxicillin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Abdominal pain"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Taste disturbance"},{"rate":"1-3","effect":"Allergic reaction (amoxicillin)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion, creating an environment where amoxicillin (a beta-lactam antibiotic) can effectively penetrate and eliminate H. pylori. This combination therapy is a standard first-line treatment for H. pylori eradication, typically used as part of triple or quadruple therapy regimens. The reduced acid environment enhances amoxicillin's bactericidal activity against the pathogen.","oneSentence":"Omeprazole reduces gastric acid while amoxicillin kills Helicobacter pylori bacteria, together eradicating H. pylori infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:24.927Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helicobacter pylori infection eradication"},{"name":"Peptic ulcer disease associated with H. pylori"}]},"trialDetails":[{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":88},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT07260006","phase":"NA","title":"Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease","status":"RECRUITING","sponsor":"Can Tho University of Medicine and Pharmacy","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection, Peptic Ulcer","enrollment":80},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT05742568","phase":"PHASE4","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-12-01","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":124},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT06973889","phase":"PHASE2","title":"Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2023-12-04","conditions":"HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease","enrollment":60},{"nctId":"NCT06851468","phase":"NA","title":"Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori","status":"NOT_YET_RECRUITING","sponsor":"Key Laboratory for Gastrointestinal Diseases of Gansu Province","startDate":"2025-03-15","conditions":"Helicobacter Pylori","enrollment":264},{"nctId":"NCT06162949","phase":"PHASE3","title":"Vonoprazan for Helicobacter Pylori Eradication in Adolescents","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Treatment Effectiveness","enrollment":242},{"nctId":"NCT06546111","phase":"PHASE1, PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Sadat City University","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection","enrollment":46},{"nctId":"NCT06502288","phase":"NA","title":"Evaluation of Antibiotic Administration Following Tooth Extraction","status":"NOT_YET_RECRUITING","sponsor":"Chittagong Medical College","startDate":"2025-01-01","conditions":"Tooth Extraction","enrollment":152},{"nctId":"NCT06250634","phase":"NA","title":"Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-02-10","conditions":"Helicobacter Pylori Infection","enrollment":806},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT03779087","phase":"NA","title":"Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Ping-I (William) Hsu, M.D.","startDate":"2018-07-11","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT06065267","phase":"PHASE4","title":"Levofloxacin Concomitant Versus Levofloxacin Sequential","status":"NOT_YET_RECRUITING","sponsor":"Damascus Hospital","startDate":"2024-01-02","conditions":"Helicobacter Pylori Infection","enrollment":150},{"nctId":"NCT04198363","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2020-04-30","conditions":"Helicobacter Pylori","enrollment":510},{"nctId":"NCT04753437","phase":"PHASE1","title":"A Study of Vonoprazan in Adults With Helicobacter Pylori","status":"COMPLETED","sponsor":"Takeda","startDate":"2021-04-06","conditions":"Helicobacter Pylori","enrollment":44},{"nctId":"NCT05863858","phase":"PHASE3","title":"Eradication of H. Pylori Infection With Moxifloxacin","status":"COMPLETED","sponsor":"Iyad Naeem Muhammad, PhD","startDate":"2020-06-01","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to","enrollment":162},{"nctId":"NCT05861687","phase":"PHASE2, PHASE3","title":"Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children","status":"COMPLETED","sponsor":"Finni Kollins","startDate":"2021-08-01","conditions":"Helicobacter Pylori Infection","enrollment":51},{"nctId":"NCT05850117","phase":"NA","title":"Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2020-02-10","conditions":"Helicobacter Pylori Eradication","enrollment":240},{"nctId":"NCT05726734","phase":"PHASE4","title":"Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT05438550","phase":"PHASE4","title":"14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-02-14","conditions":"Helicobacter Pylori Infection","enrollment":258},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT04678492","phase":"PHASE4","title":"Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":658},{"nctId":"NCT05590286","phase":"PHASE4","title":"A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2022-06-01","conditions":"Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor","enrollment":100},{"nctId":"NCT04879992","phase":"NA","title":"Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-05-07","conditions":"Helicobacter Pylori Infection","enrollment":413},{"nctId":"NCT05586464","phase":"PHASE1","title":"Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2022-11-01","conditions":"Helicobacter Pylori Infection, Traditional Chinese Medicine, Eradication","enrollment":600},{"nctId":"NCT02552641","phase":"PHASE4","title":"Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole","status":"WITHDRAWN","sponsor":"EMS","startDate":"2015-09","conditions":"Helicobacter Pylori Infection","enrollment":""},{"nctId":"NCT05176821","phase":"NA","title":"Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-01-01","conditions":"H. Pylori Infection","enrollment":186},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05189444","phase":"NA","title":"The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT05237115","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-05","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":600},{"nctId":"NCT04558502","phase":"PHASE4","title":"Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-01-05","conditions":"Helicobacter Pylori Eradication","enrollment":339},{"nctId":"NCT05100446","phase":"EARLY_PHASE1","title":"Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Unidade Local de Saúde do Alto Ave, EPE","startDate":"2021-05-01","conditions":"Helicobacter Pylori Infection, Gastritis, Gastric Cancer","enrollment":100},{"nctId":"NCT03688828","phase":"NA","title":"Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2018-11-11","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT04786938","phase":"PHASE4","title":"Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy","status":"COMPLETED","sponsor":"Universidad San Francisco de Quito","startDate":"2016-04-07","conditions":"Gut Resistome","enrollment":72},{"nctId":"NCT04024527","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-07-25","conditions":"Helicobacter Pylori Infection","enrollment":306},{"nctId":"NCT04901663","phase":"PHASE4","title":"Vonoprazan in Helicobacter Pylori Treatment an RCT","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-06-21","conditions":"Helicobacter Pylori Infection","enrollment":179},{"nctId":"NCT04907747","phase":"PHASE4","title":"Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-05-18","conditions":"Helicobacter Pylori Infection","enrollment":234},{"nctId":"NCT04626193","phase":"PHASE4","title":"LOAD VS Levofloxacine Concomitant","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2020-10-31","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT03908619","phase":"PHASE4","title":"A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2019-04-16","conditions":"Helicobacter Pylori Infection","enrollment":252},{"nctId":"NCT04348786","phase":"PHASE4","title":"Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori","status":"COMPLETED","sponsor":"Damascus Hospital","startDate":"2019-02-01","conditions":"Helicobacter Pylori Infection","enrollment":78},{"nctId":"NCT04525664","phase":"EARLY_PHASE1","title":"Assessment and Management of Chronic Dyspepsia in Eastern Uganda","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":376},{"nctId":"NCT04445948","phase":"PHASE4","title":"Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2019-11-30","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT04359966","phase":"NA","title":"Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia","status":"UNKNOWN","sponsor":"Slovenian Society for Gastroenterology and Hepatology","startDate":"2020-05-10","conditions":"Helicobacter Pylori Infection, Eradication Treatments","enrollment":560},{"nctId":"NCT03198507","phase":"PHASE3","title":"ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2017-06-18","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":455},{"nctId":"NCT04034641","phase":"PHASE4","title":"Effect of Probiotics on Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2019-06-17","conditions":"Helicobacter Pylori Eradication","enrollment":238},{"nctId":"NCT01980095","phase":"PHASE3","title":"ERADICATE Hp - Treating Helicobacter Pylori With RHB-105","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2013-11","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":119},{"nctId":"NCT03609892","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2018-08-01","conditions":"Gastric Ulcer, Chronic Gastritis, Gastric Cancer","enrollment":658},{"nctId":"NCT03557437","phase":"PHASE4","title":"High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-05-25","conditions":"Helicobacter Pylori Infection","enrollment":216},{"nctId":"NCT03968302","phase":"PHASE2","title":"ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2018-06-01","conditions":"Helicobacter Pylori Infection","enrollment":196},{"nctId":"NCT03730766","phase":"PHASE4","title":"Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-08-01","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT03405584","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT00002682","phase":"PHASE2","title":"Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1995-08-10","conditions":"Lymphoma","enrollment":5},{"nctId":"NCT03650543","phase":"PHASE4","title":"Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Javeriana University","startDate":"2012-09-10","conditions":"CYP2C19 Polymorphism, H.Pylori Infection, Therapy","enrollment":133},{"nctId":"NCT02935010","phase":"PHASE4","title":"Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2017-02-05","conditions":"Helicobacter Pylori Infection","enrollment":382},{"nctId":"NCT03413020","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT01712711","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-09","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT01654549","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":40},{"nctId":"NCT02732249","phase":"PHASE4","title":"Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2016-04-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT00404534","phase":"PHASE3","title":"Helicobacter Eradication Relief of Dyspeptic Symptoms","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2006-10","conditions":"Functional Dyspepsia","enrollment":407},{"nctId":"NCT03428568","phase":"PHASE2","title":"Safety Trial of Herbal Melanin in Gastritis Patients","status":"UNKNOWN","sponsor":"King Abdullah International Medical Research Center","startDate":"2018-03","conditions":"Acid Dyspepsia, Gastritis","enrollment":132},{"nctId":"NCT03362281","phase":"PHASE3","title":"Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2014-10","conditions":"Peptic Ulcer Hemorrhage","enrollment":540},{"nctId":"NCT00664209","phase":"PHASE3","title":"Treating H. Pylori in Parkinson's Patients With Motor Fluctuations","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2008-01","conditions":"Parkinson's Disease, Helicobacter Infections, Motor Fluctuations","enrollment":64},{"nctId":"NCT03165253","phase":"NA","title":"The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children","status":"COMPLETED","sponsor":"Bulent Ecevit University","startDate":"2011-06","conditions":"Helicobacter Pylori Infection","enrollment":69},{"nctId":"NCT01725906","phase":"PHASE4","title":"Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-11","conditions":"Self Efficacy","enrollment":450},{"nctId":"NCT00669955","phase":"PHASE3","title":"Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-06","conditions":"Helicobacter Infections","enrollment":440},{"nctId":"NCT02922699","phase":"PHASE4","title":"Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2013-01","conditions":"GERD","enrollment":120},{"nctId":"NCT02803216","phase":"PHASE1, PHASE2","title":"Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Xiyuan Hospital of China Academy of Chinese Medical Sciences","startDate":"2013-01","conditions":"Helicobacter Pylori Infection","enrollment":576},{"nctId":"NCT00201422","phase":"NA","title":"Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma","status":"COMPLETED","sponsor":"National Health Research Institutes, Taiwan","startDate":"1996-06","conditions":"MALT Lymphoma","enrollment":70},{"nctId":"NCT02689583","phase":"NA","title":"A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2016-03","conditions":"Gastritis, Gastric Ulcer","enrollment":3000},{"nctId":"NCT02296021","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2014-11","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":612},{"nctId":"NCT02395458","phase":"PHASE4","title":"Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2013-03","conditions":"Helicobacter Infections","enrollment":142},{"nctId":"NCT02090738","phase":"PHASE2","title":"A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide","status":"WITHDRAWN","sponsor":"Yonsei University","startDate":"2014-03","conditions":"H. Pylori Infection","enrollment":""},{"nctId":"NCT01938534","phase":"PHASE4","title":"Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use","status":"UNKNOWN","sponsor":"Ajou University School of Medicine","startDate":"2013-09","conditions":"Helicobacter Eradication","enrollment":440},{"nctId":"NCT02004197","phase":"PHASE2, PHASE3","title":"Quadruple and Phytomedicine-based Therapies in H. Pylori Infection","status":"COMPLETED","sponsor":"Hafiz Muhammad Asif","startDate":"2010-01","conditions":"Helicobacter Pylori [H. Pylori] as the Cause of Diseases","enrollment":176},{"nctId":"NCT01922505","phase":"","title":"Eradication Rates of Helicobacter Pylori and Its Affecting Factors","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2003-01","conditions":"Helicobacter Infections","enrollment":2500},{"nctId":"NCT01887249","phase":"PHASE4","title":"15-day Sequential Therapy for Helicobacter Pylori Infection in Korea","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2010-05","conditions":"Helicobacter Pylori Infection","enrollment":287},{"nctId":"NCT01876108","phase":"PHASE2","title":"The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-07","conditions":"Fatty Liver, Liver Dysfunction, Insulin Resistance","enrollment":100},{"nctId":"NCT01759628","phase":"PHASE2","title":"Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2012-04","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":100},{"nctId":"NCT01464060","phase":"PHASE4","title":"14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Infante, Javier Molina, M.D.","startDate":"2011-09","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT00003151","phase":"PHASE2","title":"Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1997-09","conditions":"Lymphoma","enrollment":96},{"nctId":"NCT01486082","phase":"","title":"Antimicrobial Susceptibility for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hospital Donostia","startDate":"2011-02","conditions":"Helicobacter Pylori Infection","enrollment":1},{"nctId":"NCT00772837","phase":"NA","title":"Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2006-08","conditions":"Functional Dyspepsia, Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT00723502","phase":"PHASE2","title":"Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients","status":"COMPLETED","sponsor":"MerLion Pharmaceuticals GmbH","startDate":"2008-09","conditions":"Gram-Negative Bacterial Infections, Helicobacter Infections, Dyspepsia","enrollment":30},{"nctId":"NCT00520949","phase":"NA","title":"Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2006-10","conditions":"Treatment of Helicobacter Pylori","enrollment":176},{"nctId":"NCT00854451","phase":"PHASE4","title":"Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"1996-08","conditions":"Duodenal Ulcer, Helicobacter Pylori Infection","enrollment":128},{"nctId":"NCT00719420","phase":"PHASE3","title":"Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia","status":"COMPLETED","sponsor":"University of North Texas Health Science Center","startDate":"2006-04","conditions":"Helicobacter Pylori Infection","enrollment":151},{"nctId":"NCT00455806","phase":"PHASE3","title":"Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Technische Universität Dresden","startDate":"2007-01","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"omeprazole plus amoxicillin","genericName":"omeprazole plus amoxicillin","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omeprazole reduces gastric acid while amoxicillin kills Helicobacter pylori bacteria, together eradicating H. pylori infection. Used for Helicobacter pylori infection eradication, Peptic ulcer disease associated with H. pylori.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}